• Dronedarone (Multaq): Applied Workflows in AF Research

  2026-06-24

  Harness the full potential of Dronedarone (Multaq) for atrial fibrillation research with workflow-focused protocols, troubleshooting tactics, and actionable insights from recent ion channel studies. This article details how APExBIO’s high-purity Dronedarone enables reliable, reproducible cardiac arrhythmia pharmacology.

• Polyphenol-Armored Nanogene Hydrogels for Chondrocyte Senesc

  2026-06-23

  This study presents an injectable hydrogel platform embedding polyphenol-coated, miR-140-5p-loaded nanoparticles to target chondrocyte senescence in aged osteoarthritis. The hydrogel’s adhesive and antioxidative properties enable sustained, efficient gene delivery in the joint, offering a promising direction for rejuvenating cartilage and slowing osteoarthritis progression.

• Z-YVAD-FMK Caspase-1 Inhibitor: Precision in Pyroptosis Rese

  2026-06-23

  Z-YVAD-FMK stands out as a highly selective, irreversible caspase-1 inhibitor, empowering researchers to dissect inflammasome signaling with confidence. Its robust performance in apoptosis and pyroptosis workflows offers clear advantages for oncology and inflammatory disease models, with practical troubleshooting strategies to maximize reproducibility.

• PYR-41: A Selective Inhibitor of Ubiquitin-Activating Enzyme

  2026-06-22

  PYR-41 is a potent, small molecule inhibitor of Ubiquitin-Activating Enzyme E1. It blocks the initiation of the ubiquitination cascade, providing a tool for dissecting protein degradation and NF-κB signaling. Preclinical benchmarks confirm its efficacy in both in vitro and in vivo inflammation models.

• Aging Lens Epithelial Cells Show Heightened Ferroptosis Sens

  2026-06-22

  Wei et al. identify that aging human and mouse lens epithelial cells are highly susceptible to ferroptosis, especially when glutathione peroxidase 4 (GPX4) is inhibited. Their findings reshape our understanding of cataract pathogenesis and highlight ferroptosis as a crucial cell death mechanism beyond apoptosis in ocular aging.

• Cy5 Hydrazide: Advanced Carbonyl Labeling for Protein Analyt

  2026-06-21

  Cy5 hydrazide (non-sulfonated) elevates precision in protein carbonylation labeling and nanoparticle tracking, offering distinctive advantages for both redox proteomics and food-grade nanotechnology. Seamlessly bridging oxidative stress analytics and nutraceutical delivery innovation, this dye empowers reproducible, high-sensitivity workflows beyond the reach of conventional carbonyl-reactive fluorescent dyes.

• H-Aggregated IR-1061 Enables Synergistic NIR-II Imaging and

  2026-06-20

  Yu et al. introduce a lipid nanosystem that stabilizes IR-1061 in an H-aggregated state on tumor cell membranes, unlocking dual functionality for second-window near-infrared fluorescence imaging and efficient photothermal therapy. This strategy significantly improves tumor targeting, imaging resolution, and synergistic thermochemotherapy outcomes, paving the way for advanced molecular imaging and treatment platforms.

• EZ Cap Cy5 Firefly Luciferase mRNA: Dual-Reporter for Advanc

  2026-06-19

  EZ Cap Cy5 Firefly Luciferase mRNA (5-moUTP) empowers researchers with simultaneous tracking and translation quantification, offering unmatched flexibility for optimizing mRNA delivery systems. Its dual-labeled design enables high-resolution workflow troubleshooting, immune evasion, and robust imaging—accelerating innovation in gene therapy, vaccine research, and intracellular trafficking studies.

• Gallein: Precision G Protein βγ Subunit Inhibitor Workflows

  2026-06-19

  Gallein empowers researchers to modulate GPCR signaling with exceptional specificity, enabling reproducible dissection of cancer, immune, and cardiometabolic pathways. This guide delivers actionable protocols, troubleshooting strategies, and cross-domain insights for leveraging Gallein’s unique capabilities in advanced experimental models.

• G-1: Selective GPR30 Agonist for Cardiovascular & Pain Resea

  2026-06-18

  G-1 (CAS 881639-98-1) provides nanomolar-precision for dissecting GPR30-mediated signaling in both cardiovascular and neural pain models. Its high selectivity, robust in vitro and in vivo performance, and practical compatibility with modern assay workflows make it the benchmark tool for translational estrogen receptor research.

• Panobinostat Disrupts Epigenetic Maintenance in MLL-ALL

  2026-06-18

  The highlighted study demonstrates that panobinostat, a histone deacetylase inhibitor, exerts potent anti-leukaemic effects in vivo against MLL-rearranged acute lymphoblastic leukaemia (ALL) by targeting the RNF20/RNF40/WAC-H2B ubiquitination axis. These findings clarify a key vulnerability in infant ALL and suggest new avenues for epigenetic therapy.

• Oltipraz: Optimizing Nrf2 Pathway Activation for MASLD Model

  2026-06-17

  Oltipraz, a potent 4-methyl-5-(pyrazin-2-yl)-3H-1,2-dithiole-3-thione, is redefining chemopreventive and MASLD research by enabling precise and robust Nrf2 pathway activation. This article provides actionable workflows, troubleshooting strategies, and protocol refinements to maximize the impact of Oltipraz in cellular defense and liver disease assays.

• Targeted mRNA Nanoparticles Restore BBB After Ischemic Strok

  2026-06-17

  This study demonstrates a lipid nanoparticle (LNP) system that delivers interleukin-10 mRNA specifically to M2 microglia, promoting anti-inflammatory polarization and repairing the blood-brain barrier (BBB) after ischemic stroke. The approach extends the therapeutic window and suggests a framework for precise mRNA delivery in neuroinflammatory disorders.

• ETS1 Modulates SUMOylation-Dependent Mitophagy in BPD Models

  2026-06-16

  This study identifies ETS1 as a transcriptional regulator that mitigates bronchopulmonary dysplasia (BPD) by orchestrating the SENP2/HSPA8/FUNDC1 axis to suppress sumoylation-dependent mitophagy. The findings reveal new molecular mechanisms in neonatal lung disease and suggest targeted modulation of posttranslational modifications as a promising therapeutic strategy.

• Cy5 Goat Anti-Rabbit IgG (H+L) Antibody: Transforming Fluore

  2026-06-16

  Explore how the Cy5 Goat Anti-Rabbit IgG (H+L) Antibody enhances fluorescence signal detection in advanced immunoassays. This in-depth guide unpacks its mechanism, highlights unique protocol optimizations, and offers expert insight into practical storage and assay design.

16530 records 1/1102 page Next 12345 下5页 Last page